GE HealthCare Technologies Inc. (NASDAQ:GEHC) Stock Holdings Raised by Homestead Advisers Corp

Homestead Advisers Corp lifted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 43.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 513,100 shares of the company's stock after purchasing an additional 154,700 shares during the quarter. Homestead Advisers Corp owned about 0.11% of GE HealthCare Technologies worth $40,114,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. D1 Capital Partners L.P. purchased a new stake in shares of GE HealthCare Technologies during the 3rd quarter worth about $268,159,000. Van ECK Associates Corp grew its holdings in GE HealthCare Technologies by 107.3% in the 4th quarter. Van ECK Associates Corp now owns 4,841,652 shares of the company's stock valued at $378,520,000 after buying an additional 2,506,417 shares in the last quarter. Vanguard Group Inc. increased its position in GE HealthCare Technologies by 4.3% during the fourth quarter. Vanguard Group Inc. now owns 52,537,446 shares of the company's stock worth $4,107,378,000 after purchasing an additional 2,155,429 shares during the last quarter. State Street Corp raised its position in shares of GE HealthCare Technologies by 7.8% during the 3rd quarter. State Street Corp now owns 18,615,890 shares of the company's stock valued at $1,747,101,000 after buying an additional 1,347,114 shares during the period. Finally, JPMorgan Chase & Co. grew its holdings in shares of GE HealthCare Technologies by 53.5% during the 4th quarter. JPMorgan Chase & Co. now owns 3,428,586 shares of the company's stock worth $268,047,000 after purchasing an additional 1,194,983 shares during the period. 82.06% of the stock is owned by institutional investors and hedge funds.

Remove Ads

GE HealthCare Technologies Stock Up 0.4 %

GE HealthCare Technologies stock traded up $0.36 during trading on Monday, reaching $80.37. 1,275,110 shares of the company's stock were exchanged, compared to its average volume of 2,927,238. GE HealthCare Technologies Inc. has a 52-week low of $74.51 and a 52-week high of $94.80. The firm has a market cap of $36.75 billion, a price-to-earnings ratio of 18.57, a PEG ratio of 3.19 and a beta of 1.13. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. The company's 50-day moving average is $86.70 and its two-hundred day moving average is $85.86.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.26 by $0.19. The business had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. On average, analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, May 15th. Investors of record on Friday, April 25th will be issued a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a yield of 0.17%. The ex-dividend date is Friday, April 25th. GE HealthCare Technologies's payout ratio is 3.23%.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the company. Citigroup upped their price objective on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a research report on Thursday, February 13th. The Goldman Sachs Group upgraded GE HealthCare Technologies from a "neutral" rating to a "buy" rating and lifted their target price for the stock from $85.00 to $100.00 in a research report on Tuesday, March 11th. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and lifted their price objective for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. Finally, Wells Fargo & Company increased their price target on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an "overweight" rating in a report on Friday, February 14th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, nine have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $98.75.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.